Brainomix 360 is a suite of AI-powered imaging decision-support tools for acute stroke (NCCT, CTA, CTP, MRI analysis) and lung disease (CT lung imaging), plus a network-wide analytics dashboard (Vantage); it's aimed at stroke physicians/radiologists, comprehensive and primary stroke centers, stroke networks, and pulmonology/lung-disease clinical teams. The company is a University of Oxford spinout headquartered in Oxford, UK.

Harrison.ai Comprehensive Care is an AI-assisted triage and notification (CADt) platform for chest X-ray and non-contrast head CT that flags time-sensitive and incidental findings including intracranial hemorrhage subtypes, acute infarct, obstructive hydrocephalus, pneumothorax, and vertebral compression fracture to help radiologists reprioritize worklists; it's aimed at radiologists, emergency/acute care teams, teleradiology groups, and hospital administrators. The product is developed by Harrison.ai (formerly branded Annalise.ai), an Australia-headquartered company.

RapidAI is an enterprise clinical AI platform that analyzes CT and other imaging to detect and quantify vascular and neurovascular pathology including stroke, hemorrhage, aneurysm, and pulmonary embolism and routes automated alerts to care teams; it's built for radiologists, neurologists/stroke physicians, care coordination teams, IT departments, and hospital administrators managing imaging-based service lines.